CoChat

Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo‐controlled randomized study

Pitocco, D., Zaccardi, F., Tarzia, P., Milo, M., Scavone, G., Rizzo, P., Pagliaccia, F., Nerla, R., Di Franco, A., Manto, A., Rocca, B., Lanza, G. A., Crea, F., Ghirlanda, G. · 2013 · Diabetes, Obesity and Metabolism
Cited by 72

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Aims: Several studies have investigated the effects of metformin treatment in patients with type 1 diabetes mellitus ( T1DM ). No study has hitherto examined its effects on endothelial function in these patients. In this study we sought to evaluate the effect of metformin on endothelial function in type 1 diabetic patients. Methods: Forty‐two uncomplicated T1DM patients were randomized in a placebo‐controlled, double‐blind, 6‐month trial to treatment with either metformin or placebo. Glycometabolic and clinical parameters as well as flow‐mediated dilation ( FMD ) and nitrate‐mediated dilation ( NMD ) of the right brachial artery were measured at baseline and at the end of the study. Glycaemic variability ( GV , calculated from continuous glucose monitoring data) and a biomarker of oxidative stress [urinary 8‐iso‐prostaglandin F2 α ( PGF2 α )] were also assessed. Results: Baseline data were similar in the two groups. Compared with placebo, metformin significantly reduced body weight [−2.27 kg (95% confidence interval: −3.99; −0.54); p = 0.012] whilst improved FMD [1.32% (0.30; 2.43); p = 0.013] and increased PGF2 α [149 pg/mg creatinine (50; 248); p = 0.004]. Notably, the improvement of FMD did not correlate with the decrease of body weight (r 2 < 1%). NMD , haemoglobin A1c, GV , daily insulin dose and other parameters did not significantly change after the treatment comparing the two groups. Conclusions: Our pilot trial showed that, in uncomplicated type 1 diabetic subjects, metformin improved FMD and increased PGF2 α , a marker of oxidative stress, irrespective of its effects on glycaemic control and body weight. Randomized, blinded clinical trials are needed to evaluate the benefits and risks of metformin added to insulin in type 1 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12041

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

Metadata

Authors
Pitocco, D., Zaccardi, F., Tarzia, P., Milo, M., Scavone, G., Rizzo, P., Pagliaccia, F., Nerla, R., Di Franco, A., Manto, A., Rocca, B., Lanza, G. A., Crea, F., & Ghirlanda, G.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2012-12-05
Volume
15
Issue
5
Pages
427-431
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2060328826
Cited by
72
References
11
FWCI
2.99
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.